Summit Securities Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Summit Securities Group’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$6.41K	Buy
2023 Q4	–	Hold
2023 Q3	–	Hold